Clinical Trials Browser

Phase 1 × Interventional × picropodophyllin × Clear all

NCT01062620 2011-09-15

A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumors